Explore more publications!

Press Releases

Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University
New App Aims to Standardize Before-and-After Imaging in Aesthetic Medicine
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Beauty Supplements Market to Reach $6.6 Bn by 2033 from $3.7 Bn in 2026 Driven by Wellness
Workplace Wellness Market: Analysis of Future Demand and Leading Key Players Through 2030
[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
Dyslexia Treatment Market Booming with Rapid Growth Through 2033 |  Cian Healthcare Pvt. Ltd, Novartis AG
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼
Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)
EuroAmerican Financial Advisors Launches Guide for Americans Retiring in Europe
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
8.99% Annual Growth Forecasted for the Europe Dietary Supplements Market Driven by Plant-Based Nutrition | IMARC Group
Sharpen Your Knives: It’s the Final Round of Northern California’s Battle of the Blades
Strategic Growth and Emerging Trends in the PET Sheets for Rigid Pharma Packaging Market Investments, Innovations, and Regional Shifts (2025-2035)
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Coenzyme Q10 Market to Reach $1,640M by 2032 from $789M in 2025, Boosted by Heart Health
NDSS Partners with CoorDown to Present the International Awareness Campaign “JUST EVOLVE”
DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026 
Chiesi Global Rare Diseases Announces FDA Approval of JUXTAPID® (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions